AngioDynamics Revenue vs. EBITDA
| ANGO Stock | USD 9.11 0.22 2.47% |
Total Revenue | First Reported 2001-08-31 | Previous Quarter 71 M | Current Value 67.5 M | Quarterly Volatility 29.5 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.59 | 0.509 |
|
|
For AngioDynamics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AngioDynamics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AngioDynamics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AngioDynamics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AngioDynamics over time as well as its relative position and ranking within its peers.
AngioDynamics |
AngioDynamics' Revenue Breakdown by Earning Segment
Check out Trending Equities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.05) | Revenue Per Share 7.249 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.78) |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
AngioDynamics EBITDA vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining AngioDynamics's current stock value. Our valuation model uses many indicators to compare AngioDynamics value to that of its competitors to determine the firm's financial worth. AngioDynamics is rated below average in revenue category among its peers. It is rated below average in ebitda category among its peers . At this time, AngioDynamics' Total Revenue is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AngioDynamics' earnings, one of the primary drivers of an investment's value.AngioDynamics' Earnings Breakdown by Geography
AngioDynamics Revenue vs. Competition
AngioDynamics is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 15.81 Billion. AngioDynamics claims roughly 303.91 Million in revenue contributing just under 2% to equities under Health Care industry.
AngioDynamics EBITDA vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
AngioDynamics |
| = | 303.91 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
AngioDynamics |
| = | (14.29 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
AngioDynamics EBITDA Comparison
AngioDynamics is currently under evaluation in ebitda category among its peers.
AngioDynamics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in AngioDynamics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AngioDynamics will eventually generate negative long term returns. The profitability progress is the general direction of AngioDynamics' change in net profit over the period of time. It can combine multiple indicators of AngioDynamics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -4.4 M | -4.1 M | |
| Operating Income | -192.4 M | -182.8 M | |
| Income Before Tax | -191.6 M | -182.1 M | |
| Total Other Income Expense Net | 797 K | 836.9 K | |
| Net Loss | -184.3 M | -175.1 M | |
| Income Tax Expense | -7.3 M | -6.9 M | |
| Net Loss | -47.2 M | -44.8 M | |
| Net Loss | -184.3 M | -175.1 M | |
| Non Operating Income Net Other | -637.1 K | -669 K | |
| Net Interest Income | 1.6 M | 1.7 M | |
| Interest Income | 816.3 K | 775.5 K | |
| Change To Netincome | 32.8 M | 34.4 M | |
| Net Loss | (4.59) | (4.36) | |
| Income Quality | 0.15 | 0.16 | |
| Net Income Per E B T | 0.96 | 0.94 |
AngioDynamics Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on AngioDynamics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AngioDynamics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AngioDynamics' important profitability drivers and their relationship over time.
Use AngioDynamics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.AngioDynamics Pair Trading
AngioDynamics Pair Trading Analysis
The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your AngioDynamics position
In addition to having AngioDynamics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Toys Thematic Idea Now
Toys
Companies producing and distributing toys and different gaming products for kids. The Toys theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Toys Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
To fully project AngioDynamics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of AngioDynamics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include AngioDynamics' income statement, its balance sheet, and the statement of cash flows.